GlaxoSmithKline update: Government orders for pandemic (H1N1) 2009 vaccine
- Details
- Category: GlaxoSmithKline

Avastin approved in US for the most common type of kidney cancer
- Details
- Category: Roche

Nycomed to acquire local portfolio from Sanofi-Aventis and Zentiva
- Details
- Category: Nycomed

FDA Approves ONGLYZA for the Treatment of Type 2 Diabetes in the US
- Details
- Category: AstraZeneca

AstraZeneca PLC Second Quarter & Half Year Results 2009
- Details
- Category: AstraZeneca

Good first six months in 2009 for Boehringer Ingelheim
- Details
- Category: Boehringer Ingelheim

Pfizer in Partnership with Shanghai Institutes for Biological Sciences for Drug Discovery Activities
- Details
- Category: Pfizer

More Pharma News ...
- Abbott to Acquire Nutrition Businesses, Expanding Presence in India
- Amgen to collaborate with GSK to commercialize denosumab in Europe for postmenopausal osteoporosis
- Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29
- Q2/2009: Merck Revenues Remain Steady at € 1.9 Billion
- The US Food and Drug Administration (FDA) has approved Tekturna HCT®
- Genzyme Delivers Solid Second-Quarter Financial Results
- Pfizer Reports Second-Quarter 2009 Revenues of $11.0 Billion